Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mesenchymal stem cells (Innovita Research)
- Development stage
- Preclinical
- Lead developer
- Innovita Research
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Innovita Research's mesenchymal stem cells (MSCs) are a cord tissue-derived cell therapy product currently in preclinical development for research applications, including anti-aging and regenerative medicine. Manufactured according to EU GMP standards, these cells are characterized by a specific immunophenotype (CD73+, CD90+, CD105+, and CD45-). The product is formulated as a frozen suspension containing approximately 100 million cells per 24 ml bag in a DMSO-DEX/15% Human Albumin solution, designed for intravenous infusion. MSCs are known for their multipotent differentiation potential and their ability to modulate the immune system and promote tissue repair through paracrine signaling. Innovita Research explores these cells within their broader R&D portfolio, which includes lifespan prolongation studies (Project M) and mitochondrial transfer technologies.
- Other names
- cord tissue-derived mesenchymal stem cellsUC-MSCumbilical cord mesenchymal stem cells
Beyond the preview
Go deeper on mesenchymal stem cells (Innovita Research).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mesenchymal stem cells (Innovita Research).